USFDA issues warning letter to Cipla for Goa manufacturing facility

USFDA issues warning letter to Cipla for Goa manufacturing facility The company further said that it remains committed to maintaining the highest standards of compliance and will work closely with the agency to comprehensively address all the observations

No comments:

Post a Comment